Although the Smith & Nephew Genesis II and Journey II bicruciate stabilized knee implants had no differences in 6-month patient-reported outcomes, results showed the Genesis II yielded significant advantages for knee range of movement.
Researchers randomly assigned 80 patients undergoing single-stage total knee replacement to receive either the Genesis II (Smith & Nephew) TKR or the Journey II bicruciate stabilized (Smith & Nephew) knee implant. The primary outcome was the Oxford Knee Score at 6 months. Secondary outcomes were the OKS activity.
